By prioritizing public safety, combating the opioid epidemic, and bolstering our nation’s research and technology edge
Mark Alford will prioritize combating the opioid epidemic.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
The office's visible June 2026 press-release list in the lookback window covers disaster-declaration advocacy, a missing-persons bill, appropriations, housing, and defense items. No opioid, fentanyl, naloxone, or addiction-specific action is surfaced on the page.
legacy_unverified · Source version not recorded · locator unknown
The homepage's current featured-news and issue sections emphasize disaster relief, defense, housing, agriculture, small business, and veterans. Health or opioid policy is not surfaced there as a featured priority.
legacy_unverified · Source version not recorded · locator unknown
Roll Call 166 was on passage of S.331, the HALT Fentanyl Act. The vote status was Passed, 321 yeas to 104 nays, and the all-votes table lists Rep. Alford, Republican, Missouri, voting Yea.
legacy_unverified · Source version not recorded · locator unknown
Congress.gov lists S.331 as law, with latest action on 07/16/2025: Became Public Law No. 119-26. It states the bill passed the House on 06/12/2025 by 321-104, Roll no. 166, and the summary says the act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act.
legacy_unverified · Source version not recorded · locator unknown
Public Law 119-26 is titled the Halt All Lethal Trafficking of Fentanyl Act. The enacted text amends the Controlled Substances Act with respect to scheduling fentanyl-related substances and adds schedule I coverage for materials containing any quantity of a fentanyl-related substance, unless exempted or listed elsewhere.
legacy_unverified · Source version not recorded · locator unknown
Roll Call 33 was on passage of H.R.27, the HALT Fentanyl Act. The vote status was Passed, 312 yeas to 108 nays, and the all-votes table lists Rep. Alford, Republican, Missouri, voting Yea.
legacy_unverified · Source version not recorded · locator unknown
Congress.gov lists H.R.27 as the HALT Fentanyl Act, sponsored by Rep. H. Morgan Griffith and passed by the House on 02/06/2025 by 312-108. Its CRS summary says the bill permanently places fentanyl-related substances as a class into schedule I and subjects offenses involving those substances to the same quantity thresholds and penalties as fentanyl analogues.
legacy_unverified · Source version not recorded · locator unknown
Congress.gov lists S.206, the END FENTANYL Act, as Public Law No. 118-43. It passed the House by voice vote on 03/07/2024 and requires CBP to update inspection manuals and policies to respond to changes used to disguise illegal activity such as drug and human smuggling.
legacy_unverified · Source version not recorded · locator unknown
Alford's office said the FY2027 Commerce-Justice-Science bill passed the House Appropriations Committee and that, as a committee member, Alford secured district investments and priorities including a Bureau of Prisons wastewater-surveillance pilot for drug use involving fentanyl and other synthetic opioids. The statement also characterized the bill as prioritizing combating the opioid epidemic.
legacy_unverified · Source version not recorded · locator unknown
A mirror of Alford's official X account showed a recent post saying fentanyl deaths had fallen 22%, from about 49,000 to 38,000 in one year, and tying fentanyl prevention to border security.
Assessments
Alford took same-term federal actions related to the opioid/fentanyl crisis, including voting for the HALT Fentanyl Act that became Public Law 119-26 and participating in appropriations committee work that included fentanyl and synthetic-opioid monitoring. Those actions show meaningful attention to opioid-related policy. However, the strongest enacted result was not his sponsored bill, and the record shows limited evidence that opioid response was a sustained top priority across his agenda. This supports partial fulfillment rather than full delivery.
The promise is broad and priority-based rather than tied to a specific measurable federal outcome. In the evidence provided, Mark Alford's current official House website and June 2026 press-release activity do not surface opioid-, fentanyl-, naloxone-, or addiction-specific initiatives, which weakens a claim that this has been a visible governing priority. But the record here is also too thin to conclude definitively that he never acted on the issue anywhere in his congressional work. Because there is no clear documented delivery and not enough evidence of sustained opioid-focused action or of a serious failed push, the most defensible judgment is unresolved rather than delivered, partial, or never.